Your browser doesn't support javascript.
loading
Hepatitis A vaccine immunogenicity 25 years after vaccination in Alaska.
Ramaswamy, Maya; Bruden, Dana; Nolen, Leisha D; Mosites, Emily; Snowball, Mary; Nelson, Noele P; Bruce, Michael; McMahon, Brian J.
Afiliação
  • Ramaswamy M; Arctic Investigations Program, Division of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, Alaska.
  • Bruden D; Arctic Investigations Program, Division of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, Alaska.
  • Nolen LD; Arctic Investigations Program, Division of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, Alaska.
  • Mosites E; Arctic Investigations Program, Division of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, Alaska.
  • Snowball M; Liver Disease and Hepatitis Program, Alaska Native Tribal Health Consortium, Anchorage, Alaska.
  • Nelson NP; Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Anchorage, Alaska.
  • Bruce M; Arctic Investigations Program, Division of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, Alaska.
  • McMahon BJ; Liver Disease and Hepatitis Program, Alaska Native Tribal Health Consortium, Anchorage, Alaska.
J Med Virol ; 93(6): 3991-3994, 2021 06.
Article em En | MEDLINE | ID: mdl-33448443
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Acesso_medicamentos_insumos_estrategicos Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: Vacinas contra Hepatite A / Anticorpos Anti-Hepatite A / Imunogenicidade da Vacina / Hepatite A Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Child, preschool / Female / Humans / Male País/Região como assunto: America do norte Idioma: En Revista: J Med Virol Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Acesso_medicamentos_insumos_estrategicos Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: Vacinas contra Hepatite A / Anticorpos Anti-Hepatite A / Imunogenicidade da Vacina / Hepatite A Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Child, preschool / Female / Humans / Male País/Região como assunto: America do norte Idioma: En Revista: J Med Virol Ano de publicação: 2021 Tipo de documento: Article